Reproterol Hydrochloride

盐酸瑞普特罗

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameReproterol Hydrochloride
Drug Alias Namereproterol盐酸茶丙喘宁reproterolumBronchodilW-2946M +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma, Exercise-InducedAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeda Pharma Gmbh & Co Kg
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsAsthma, Exercise-Induced

Other Information

ATC CodeR03AC15R03CC14
Related LinksWikipediaKEGG